Transcatheter aortic valve replacement was associated with improved survival in high-risk patients with diabetes and aortic stenosis, according to new research. Mortality at one year was 18% in patients treated with TAVR, compared with 27.4% in those who had surgical aortic valve replacement. The results were presented at the European Society of Cardiology Congress.
Study: TAVR lowers mortality in high-risk diabetes patients
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|